150 related articles for article (PubMed ID: 23664876)
1. Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor.
Pathuri G; Thorpe JE; Disch BC; Bailey-Downs LC; Ihnat MA; Gali H
Bioorg Med Chem Lett; 2013 Jun; 23(12):3561-4. PubMed ID: 23664876
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.
Pathuri G; Hedrick AF; Disch BC; Doan JT; Ihnat MA; Awasthi V; Gali H
Bioconjug Chem; 2012 Jan; 23(1):115-24. PubMed ID: 22148582
[TBL] [Abstract][Full Text] [Related]
3. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
4. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
7. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
8. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice.
Dehelean CA; Feflea S; Gheorgheosu D; Ganta S; Cimpean AM; Muntean D; Amiji MM
J Biomed Nanotechnol; 2013 Apr; 9(4):577-89. PubMed ID: 23621016
[TBL] [Abstract][Full Text] [Related]
10. Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold.
Pauli FP; Martins JR; Paschoalin T; Ionta M; Barbosa MLC; Barreiro EJ
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000130. PubMed ID: 32667721
[TBL] [Abstract][Full Text] [Related]
11. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
Mu X; Shi W; Sun L; Li H; Jiang Z; Zhang L
Molecules; 2012 Jun; 17(6):6854-68. PubMed ID: 22669041
[TBL] [Abstract][Full Text] [Related]
12. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
18. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
[TBL] [Abstract][Full Text] [Related]
19. Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation.
Zhang Y; He L; Meng L; Luo W
Vascul Pharmacol; 2008; 48(2-3):129-37. PubMed ID: 18304881
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents.
Wang P; She G; Yang Y; Li Q; Zhang H; Liu J; Cao Y; Xu X; Lei H
Molecules; 2012 Apr; 17(5):4972-85. PubMed ID: 22547319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]